Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 2 (5-HT2) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serotonin receptor | 0.0156 | 0.5724 | 0.5621 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Leishmania major | protein kinase, putative | 0.0002 | 0 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | Serotonin receptor | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | neuropeptide F receptor | 0.0009 | 0.0236 | 0.5 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0002 | 0 | 0.5 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0002 | 0 | 0.5 |
Brugia malayi | Dopamine receptor protein 1 | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | Dopamine receptor | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | AKH receptor | 0.0009 | 0.0236 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.027 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | Serotonin/octopamine receptor family protein 7 | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | putative neuropeptide receptor | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | gonadotropin-releasing hormone receptor 2 | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Echinococcus multilocularis | serotonin receptor | 0.0156 | 0.5724 | 0.5621 |
Brugia malayi | G protein-coupled receptor F59B2.13 | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | Dopamine receptor protein 1, putative (partial) | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | sulfakinin receptor protein | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | larval opioid receptor | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | Dopamine receptor protein 2 | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | GnHR receptor homolog | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | RE15519p | 0.0009 | 0.0236 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.027 | 1 | 1 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Leishmania major | serine-threonine protein kinase-like protein | 0.0002 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | Unidentified vitellogenin-linked transcript protein 6, putative | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | G-protein-linked acetylcholine receptor protein 2, putative | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0156 | 0.5724 | 0.5621 |
Brugia malayi | G-protein coupled receptor | 0.0009 | 0.0236 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.5724 | 1 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | Melatonin receptor type 1A | 0.0009 | 0.0236 | 0.5 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0002 | 0 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | G protein-coupled receptor | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | G-protein coupled receptor | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | Tachykinin-like peptides receptor 99D | 0.0009 | 0.0236 | 0.5 |
Leishmania major | protein kinase, putative | 0.0002 | 0 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase I | 0.027 | 0.9996 | 0.9996 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Trypanosoma brucei | Forkhead Kinase, putative | 0.0002 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase I | 0.027 | 0.9996 | 0.9996 |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | hypothetical protein | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | ORL1-like opioid receptor | 0.0009 | 0.0236 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.5724 | 1 |
Brugia malayi | Serotonin receptor | 0.0009 | 0.0236 | 0.5 |
Brugia malayi | putative neuropeptide receptor NPR1 | 0.0009 | 0.0236 | 0.5 |
Onchocerca volvulus | 0.0009 | 0.0236 | 0.5 | |
Brugia malayi | follicle stimulating hormone receptor | 0.0009 | 0.0236 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0156 | 0.5724 | 0.5621 |
Echinococcus multilocularis | serine:threonine protein kinase Chk2 | 0.027 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.027 | 1 | 1 |
Brugia malayi | neuropeptide F receptor | 0.0009 | 0.0236 | 0.5 |
Leishmania major | protein kinase, putative | 0.0002 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 31 % | Inhibitory activity against Dopamine receptor D2 of rat limbic tissue at 1 uM | ChEMBL. | 10602693 |
Ki (binding) | = 4.3 nM | Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor | ChEMBL. | 10602693 |
Ki (functional) | = 10 nM | Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor | ChEMBL. | 10602693 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.